|
|
|
THE JOURNAL OF THE CANADIAN PAEDIATRIC SOCIETY
APPENDIX 1
Temporal criteria for inclusion of adverse events |
| |
Adverse event code(s)*
|
| Immunizing agent |
1-4
|
5-6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
| MMRVac |
5-30 days
|
n/a
|
<48 h
|
5-30 days
|
<72 h
|
5-30 days
|
<24 h
|
<72 h
|
5-30 days
|
5-30 days
|
| DPT/DPTP |
<72 h
|
n/a
|
<48 h
|
<7 days
|
<72 h
|
<7days
|
<24 h
|
<72 h
|
–
|
<72 h
|
| Other† |
<72 h
|
n/a
|
<48 h
|
–
|
<72 h
|
<7days
|
<24 h
|
<72 h
|
–
|
<7 days
|
| Immunizing agent |
15
|
16
|
17
|
18-19
|
20
|
21
|
22
|
23-24
|
25
|
26
|
| MMRVac |
72 h
|
5-30 days
|
5-30 days
|
5-30 days
|
5-30 days
|
<31days
|
n/a
|
5-30 days
|
<31days
|
–
|
| DPT/DPTP |
72 h
|
<72 h
|
<7 days
|
<15 days
|
<15 days
|
<31days
|
n/a
|
n/a
|
<31 days
|
–
|
| Other† |
72 h
|
<15 days
|
<15 days
|
<15 days
|
<15 days
|
<31days
|
n/a
|
n/a
|
<31 days
|
–
|
| Note that the time
from vaccine administration to onset of symptoms must be with in the
time frame listed below for eac h kind of adverse event. All sudden
infant deat h syndromes deaths were excluded because they were deemed
to be unrelated to vaccine administration according to previously
published papers. *As defined in Table 10; †Applies
only to nonoral poliio vaccine-related events. For oral polio vaccine-related
events, the time interval is four to 60 days. For influenza-related
events, there is no time restriction. DPT/DPTP Diphtheria, pertussis,
tenanus/diphtheria, pertussis, tentanus, polio; MMRVAC Measles, mumps,
rubella vaccine; n/a Not applicable; – Undefined |
[Previous]
[Table of Contents] [Next]
|
